Endovascular management and the risk of late failure in the treatment of ureteroarterial fistulas

Authors

George Titomihelakis, Thomas Jefferson UniversityFollow
Anthony Feghali, Thomas Jefferson UniversityFollow
Tuong Nguyen, Thomas Jefferson UniversityFollow
Dawn Salvatore, Thomas Jefferson UniversityFollow
Paul DiMuzio, Thomas Jefferson UniversityFollow
Babak Abai, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

9-17-2019

Comments

This article has been peer reviewed. It is the author’s final published version in Journal of Vascular Surgery Cases and Innovative Techniques, Volume 5, Issue 4, December 2019, Pages 396-401.

The published version is available at https://doi.org/10.1016/j.jvscit.2019.06.010. Copyright © Titomihelakis et al.

Abstract

Ureteroarterial fistula (UAF) is a rare and life-threatening source of hematuria. A high index of suspicion is warranted for early diagnosis and timely intervention. Because of high perioperative risk and comorbidities in UAF patients, the endovascular approach has become preferred for repair. Infection can complicate this mode of therapy, and treatment with antibiotics is important. Herein we present five cases of secondary UAFs treated with stent graft alone or stent graft and embolization.

Recommended Citation

Titomihelakis, George; Feghali, Anthony; Nguyen, Tuong; Salvatore, Dawn; DiMuzio, Paul; and Abai, Babak, "Endovascular management and the risk of late failure in the treatment of ureteroarterial fistulas" (2019). Department of Medicine Faculty Papers. Paper 262.
https://jdc.jefferson.edu/medfp/262

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English